Novel analogs of d-e-MAPP and B13. Part 1: Synthesis and evaluation as potential anticancer agents
- 15 January 2008
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 16 (2), 1015-1031
- https://doi.org/10.1016/j.bmc.2007.08.033
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Novel analogs of d-e-MAPP and B13. Part 2: Signature effects on bioactive sphingolipidsBioorganic & Medicinal Chemistry, 2008
- Lysosomal Sequestration of Amine-Containing Drugs: Analysis and Therapeutic ImplicationsJournal of Pharmaceutical Sciences, 2007
- A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell deathBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Glucosylceramide Synthase Blockade Down-Regulates P-Glycoprotein and Resensitizes Multidrug-Resistant Breast Cancer Cells to Anticancer DrugsCancer Research, 2005
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue‐type plasminogen activatorThe FASEB Journal, 2004
- Liposomal Delivery Enhances Short-Chain Ceramide-Induced Apoptosis of Breast Cancer CellsJournal of Pharmacology and Experimental Therapeutics, 2003
- Synthesis and cytotoxicity of new 3-alkyl-1-(1-methyl-2-phenylethyl)ureas related to ceramideArchives of Pharmacal Research, 2003
- Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosisBiochemical and Biophysical Research Communications, 2002
- (1S,2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol as an Inhibitor of CeramidasePublished by Elsevier BV ,1996